QA: Protea Biosciences Group Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001335103_2016_Protea_Biosciences_Group_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001335103, Protea Biosciences Group Inc

  xvar xval
0 AssetsCurrent 411,591
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,626,907
3 remainder_Assets 5,248
4 LiabilitiesCurrent 9,590,170
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 743,744
8 SellingGeneralAndAdministrativeExpense 6,956,062
9 ResearchAndDevelopmentExpense 1,676,381
10 remainder_Expenses 0
11 remainder_Revenues 2,220,755
12 remainder_NetIncome -984,720
13 remainder_ComprehensiveNetIncome -18,471
  yvar yval
0 Assets 3,043,746
1 Liabilities 9,590,170
2 Expenses 9,376,187
3 Revenues 2,220,755
4 StockholdersEquity -6,546,424
5 NetIncome -8,140,152
6 ComprehensiveNetIncome -8,149,388
7 BaseVar 12,617,024
8 EconomicCapitalRatiobeforeLimitedLiability -3.55
9 EconomicCapitalRatio 0.515

Edgar->Model Mapping

Feature Distribution

Change over Time